The problem with alternate treatments is it requires a tremendously expensive procedure—clinical trials—to get them approved for use. To get the financing you will need an organized effort and that could open up the door to people taking the money to their offshore banks.
My list of the Wakefield-type grifters and misinformation sources:
Dr. Juli A. Mazi (fake homeoprophylaxis immunizations), Dr. Michael Yeaden, Robert Malone, Joseph Mercola (Mercola Com Health Resources LLC), Robert F. Kennedy Jr. (Children’s Health Defense Co), Julie Masy, Ty & Charlene Bollinger, Keith Middlebrook (COVID pills), Sherri Tenpenny (Tenpenny Integrative Medical Center), Rizza Islam, Rashid Buttar, Erin Elizabeth, Sayer Ji, Kelly Brogan, Christiane Northrup, Ben Tapper, Kevin Jenkins, Barbara Loe Fisher (The National Vaccine Information Center), Del Bigtree (Informed Consent Action Network), Edwin Tamasese and Dr. Simone Gold (Frontline Doctors).
You criticize Big Pharma but do you consider the huge cost of research and development, testing and production for something like Pfizer’s mRNA vaccine for COVID-19? The money does not come out of thin air. They don’t just mash up some Chinese tree bark and make an injection from it. After the meticulous makeup that messenger RNA has to be kept at minus 74 degrees Fahrenheit because of the unstable nature of the RNA blueprint. That takes a lot of money to come up with that technology. That money does not come out of thin air. It comes out of the sum total of the successful application that saves human life enough that people pay money for it. What? Do you want Pfizer and Moderna to lose money on it?
If you want alternative treatments for COVID-19 (DELTA) why don’t you organize a team to raise the money for the research and development, the testing and production and distribution? If you say that ivermectin has already been created and has passed the trials and has FDA approval, there is one problem. They do not know if the necessary dose to treat COVID is safe for humans and will be effective. Clinical trials have to be done to learn the answer to many questions. If the trials do not show ivermectin is safe at the necessary dose, then out goes that remedy after much expense.
The average cost of phase 1, 2, and 3 clinical trials across therapeutic areas is around $4, 13, and 20 million respectively. Pivotal (phase 3) studies for new drugs approved by the Food and Drug Administration (FDA) cost a median of $41,117 per patient. Who is willing to take a chance on ivermectin for COVID?